 |
12 Diseases |  |
138 Trials |
|
138 Trials |  |
3994 News |  |
| «12...345678910111213...3940» |
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk, Norditropin (somatropin) / Novo Nordisk
@novonordiskus @teamnovonordisk @novonordisk What is the update on the Norditropin shortage. The shortage dates keep getting pushing out with little communication. You are playing with the lives of adolescents in favor of Ozempic / Wegovy for $$$. (Twitter) - Jul 6, 2023
- ||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Trial completion: A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes (clinicaltrials.gov) - Jul 6, 2023
P1, N=101, Completed, Sponsor: Novo Nordisk A/S
Active, not recruiting --> Completed
- || Ozempic (semaglutide SC once-weekly) / Novo Nordisk, Saxenda (liraglutide 3 mg) / Novo Nordisk
I'd like your opinion on using Ozempic, Wegovy and Saxenda for weight loss. I know 2 non diabetic people using them. I have mixed feelings. Thanks (Twitter) - Jul 5, 2023
- ||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Vi taler for lidt om, at @NovoNordisk har så travlt med at producere Wegovy til fedmebehandling at der ikke er nok Semaglutid til at de kan levere #Ozempic til os der er i diabetesbehandling! @DiabetesDK (Twitter) - Jul 4, 2023
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk, Mounjaro (tirzepatide) / Eli Lilly
Strange, since the price of Wegovy is almost same as Mounjaro and Mounjaro offers more weightloss hence better cost / benefit ratio. Decision does not add up. At all. (Twitter) - Jul 4, 2023
- ||| hydroxychloroquine / Generic mfg., Ozempic (semaglutide SC once-weekly) / Novo Nordisk, ivermectin oral / Generic mfg.
Using drugs off label has been around for decades but when it came to covid #ivermectin and HCQ were off limits but #ozempic is ok. I’m all of off label but per usual wait and see (Twitter) - Jul 3, 2023
- ||||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk, cagrilintide (AM833) / Novo Nordisk, cagrilintide/semaglutide (CagriSema) / Novo Nordisk
Enrollment closed, Combination therapy: REDEFINE 1: A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight (clinicaltrials.gov) - Jul 3, 2023
P3, N=3400, Active, not recruiting, Sponsor: Novo Nordisk A/S
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- || Ozempic (semaglutide SC once-weekly) / Novo Nordisk
You don't load folks up on Ozempic. No one is knocking chemotherapeutics here. (Twitter) - Jul 2, 2023
- || Ozempic (semaglutide SC once-weekly) / Novo Nordisk
New with added Wegovy. Free bag of Olestra chips on the side. Code brown assistance not supplied! (Twitter) - Jun 30, 2023
- ||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Reimbursement, US reimbursement, Medicaid: If they have DM, won’t Medicaid cover Ozempic? (Twitter) - Jun 27, 2023
- || Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Enrollment open: A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease (clinicaltrials.gov) - Jun 27, 2023
P3, N=24, Recruiting, Sponsor: Novo Nordisk A/S
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Journal: Sustained weight loss with semaglutide once weekly in patients without type 2 diabetes and post-bariatric treatment failure. (Pubmed Central) - Jun 26, 2023
Treatment options to manage post-bariatric treatment failure are scarce. Our results imply a clear benefit of adjunct treatment with semaglutide in post-bariatric patients over a 12 months follow-up period.
- ||| Rybelsus (semaglutide oral) / Novo Nordisk, Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Very exciting about promising new oral GLP-1 data presented at #ADA2023. But a total miss by @nytimes on the headline since there is already a pill form of Ozempic called Rybelsus. https://t.co/B37slewX33 (Twitter) - Jun 26, 2023
- ||||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Clinical: The drugmakers behind Ozempic and other diabetes and weight loss drugs are now racing to develop a daily pill for people who want to lose weight. Dr. @CelineGounder shares when the pills could become available — and some of the risks involved. https://t.co/G9FhH4aVxV (Twitter) - Jun 26, 2023
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk
To, co działa. Zmiana nawyków odżywiania, akt fizyczna i praca nad głową. Jeśli w głowie się nie ułoży, wajcha nie przestawi, nie ma takiej siły, żeby spadek wagi był skuteczny. Czy to będzie ozempic czy bariatria. (Twitter) - Jun 25, 2023
- ||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk
The more people that take Ozempic because they want to shed a few pounds, the less there will be for the type 2 diabetics that really need it! #MedEd #MedTwitter #ozempic @DrIanWeissman @FriedbergEric @rstraxMD @alldiabetesnews @IntDiabetesFed @anthonyanderson (Twitter) - Jun 25, 2023
- ||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Clinical: @novonordisk stock falls on Ozempic 'safety signal' to Thyroid cancer https://t.co/CYuQXcS679 via @YahooFinance @PharmRJ (Twitter) - Jun 24, 2023
- || Ozempic (semaglutide SC once-weekly) / Novo Nordisk
@Independent front page screamer: UK shortage of Ozempic Obesity drug/Diabetes/Wegomy. @novonordisk boom? Factory nobrainer? Time4Change @olivershah @iancowie @AlbertBourla @USAmbUK @SECO_StateSec @wjlonghurst @olyduff @NikkiHaley @elonmusk @timkaine @CNOEngland @Louie_Horne (Twitter) - Jun 24, 2023
- || Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Reviewing the Q1 2023 earning report of @novonordisk (maker of #ozempic). The U.S. had the LARGEST % increase in sales @ 46%. 🇺🇸 is a gold mine for selling drugs. As seen on TV 😉 (Twitter) - Jun 24, 2023
- | Rybelsus (semaglutide oral) / Novo Nordisk, Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Ozempic and more recently Rybelsus (Twitter) - Jun 24, 2023
- || Ozempic (semaglutide SC once-weekly) / Novo Nordisk
#Ozempic (Twitter) - Jun 23, 2023
- || Ozempic (semaglutide SC once-weekly) / Novo Nordisk
- los médicos: "no usen Ozempic para bajar de peso a lo loco" - @novonordisk, la empresa que fabrica Ozempic: sigue gastando plata en avisos en Facebook "para que manejes tu peso" 🤑 (Twitter) - Jun 23, 2023
- ||||| LAI287/semaglutide (NN1535) / Novo Nordisk, Ozempic (semaglutide SC once-weekly) / Novo Nordisk, Awiqli (insulin icodec) / Novo Nordisk
Enrollment closed: A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2) (clinicaltrials.gov) - Jun 22, 2023
P3, N=680, Active, not recruiting, Sponsor: Novo Nordisk A/S
Our results imply a clear benefit of adjunct treatment with semaglutide in post-bariatric patients over a 12 months follow-up period. Recruiting --> Active, not recruiting
- || Ozempic (semaglutide SC once-weekly) / Novo Nordisk
I am not sure why that would be the case. I have used Ozempic for about 5 years and almost all my weight loss has been accompanied by a reduction in trunk dimensions and a much-improved A1C. Are you suggesting that Ozempic will result in loss of bone or muscle mass? (Twitter) - Jun 21, 2023
- || Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Problem is going to become more pronounced with the mass introduction of Semaglutide drugs like Ozempic. Only a Dexa is going to show that. (Twitter) - Jun 21, 2023
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Journal, Real-world evidence, Real-world: Results of semaglutide in patients older than 70 years, a real-world study of efficacy and safety. (Pubmed Central) - Jun 20, 2023
Recruiting --> Active, not recruiting In routine clinical practice in Spain, the use of semaglutide once a week was associated with statistically significant and clinically relevant improvements in HbA1c and body weight in adults aged over 70 years with T2DM, without notable adverse effects, which supports real-world use.
- || Ozempic (semaglutide SC once-weekly) / Novo Nordisk
My latest in @Forbes ! Why Ozempic May Not Be Right For You! https://t.co/vQAH75OUiS. @DrIanWeissman @nkagetsu @FriedbergEric @rstraxMD @DrLindaMD @meganranney @elonmusk @DrFerdowsi @aimcradig @mahad_minhas (Twitter) - Jun 19, 2023
- || Ozempic (semaglutide SC once-weekly) / Novo Nordisk
My latest in @Forbes ! Why Ozempic May Not Be Right For You! https://t.co/vQAH75OUiS. #Ozempic #publichealth @MohitAgNeurorad @Vilavaite @AminaFarooqMD @koolkpMD @alihusnain186 @AliTejaniMD @RasuShrestha @TLHM_MD @celinegounder @Centivox @choo_ek (Twitter) - Jun 19, 2023
- || Ozempic (semaglutide SC once-weekly) / Novo Nordisk
And in the case of Ozempic prescribe it for everything (Twitter) - Jun 18, 2023
- ||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Very interesting. I feel that the ozempic shortage is going to get worse if it’s preventing cancer as well! (Twitter) - Jun 16, 2023
- ||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk
The @AmDiabetesAssn jumps on the bandwagon claiming obesity is no longer caused by too much or the wrong foods. I'm guessing it's caused by an Ozempic deficiency. (Apparently Ozempic is "holistic".) @DikemanDave @ryanattar @SBakerMD (Twitter) - Jun 15, 2023
- | retatrutide (LY3437943) / Eli Lilly
Journal: Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity? (Pubmed Central) - Jun 14, 2023
Retatrutide also needs to be compared to another Eli Lilly and Company drug, the combined GLP-1 and GIP receptor agonist, tirzepatide. The safety of retatrutide needs to be determined in larger and longer trials.
- | Alecensa (alectinib) / Roche
New P4 trial: The influence of different DIets on ALECTinib exposure in lung cancer patients;the DIALECT study. (EUDRACT) - Jun 13, 2023
P4, N=10, Ongoing, Sponsor: null
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Do you have any date WY wegovy will be offered again (Twitter) - Jun 13, 2023
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Oh wow. Does it work the same as Wegovy? (Twitter) - Jun 13, 2023
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Ozempic 0,5 og 1,0 i retsordre. Kan @novonordisk skrue op for produktion? Vi udskriver til 4x0,25 hvilket giver Novo den 4 dobbelte indtægt og @regionerne den 4 dobbelte udgift. Sådan ædes vores sundhedskroner op @SSTSundhed @DKsundhed #sundpol @zacho_broe (Twitter) - Jun 13, 2023
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Journal: Wegovy: Weight loss drug to be available from GPs in pilot scheme. (Pubmed Central) - Jun 12, 2023
The safety of retatrutide needs to be determined in larger and longer trials. No abstract available
- ||||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Clinical: Semaglutide 2.4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomize, placebo-controlled phase 2 trial→https://t.co/rLSfdY8Zaj @DrLoomba @Mayo_liverdoc @Drfattyliver @EricLawitz @VladRatziu @VCU_Liver @schattenbergJ @phil_newsome7… https://t.co/zQIhn5cl19 (Twitter) - Jun 12, 2023
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk, Saxenda (liraglutide 3 mg) / Novo Nordisk
My doctor switched me to Saxenda today. We were both sick of the runaround with Wegovy. (Twitter) - Jun 12, 2023
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Enrollment open: SEMALCO: Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity? (clinicaltrials.gov) - Jun 12, 2023
P2, N=108, Recruiting, Sponsor: Psychiatric Centre Rigshospitalet
No abstract available Not yet recruiting --> Recruiting
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Journal: Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype. (Pubmed Central) - Jun 9, 2023
P3
Not yet recruiting --> Recruiting In total, STEP-HFpEF program randomized 1,146 participants with the obesity phenotype of HFpEF and will determine whether semaglutide improves symptoms, physical limitations, and exercise function in addition to weight loss in this vulnerable group.
- ||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Trial completion date, Trial primary completion date: Latino Semaglutide Study (clinicaltrials.gov) - Jun 9, 2023
P3, N=100, Recruiting, Sponsor: Loma Linda University
In total, STEP-HFpEF program randomized 1,146 participants with the obesity phenotype of HFpEF and will determine whether semaglutide improves symptoms, physical limitations, and exercise function in addition to weight loss in this vulnerable group. Trial completion date: Jan 2024 --> May 2024 | Trial primary completion date: May 2023 --> May 2024
- ||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Trial completion date, Trial primary completion date: A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial) (clinicaltrials.gov) - Jun 9, 2023
P3, N=105, Recruiting, Sponsor: Novo Nordisk A/S
Trial completion date: Jan 2024 --> May 2024 | Trial primary completion date: May 2023 --> May 2024 Trial completion date: Jul 2024 --> Nov 2024 | Trial primary completion date: Jun 2023 --> Oct 2024
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk
New trial: SEMASEARCH, Retrospective/Prospective Cohort Nested at ATUc/AP2 WEGOVY (clinicaltrials.gov) - Jun 9, 2023
P=N/A, N=1000, Not yet recruiting, Sponsor: Hospices Civils de Lyon
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk
New P2 trial: SEMALCO: Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity? (clinicaltrials.gov) - Jun 8, 2023
P2, N=108, Not yet recruiting, Sponsor: Psychiatric Centre Rigshospitalet
- |||| Ozempic (semaglutide SC once-weekly) / Novo Nordisk
New P3 trial: A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease (clinicaltrials.gov) - Jun 7, 2023
P3, N=24, Not yet recruiting, Sponsor: Novo Nordisk A/S
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk
. @novonordisk’s Wonder Diet Drug #Ozempic May Land in China Soon https://t.co/JzrX2cM7iJ (Twitter) - Jun 5, 2023
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Observational data, Journal: Once-weekly semaglutide use in patients with type 2 diabetes: results from the SURE France multicentre, prospective, observational study. (Pubmed Central) - Jun 5, 2023
Trial completion date: Jul 2024 --> Nov 2024 | Trial primary completion date: Jun 2023 --> Oct 2024 These results support the benefits of semaglutide in a real-world setting in adults with T2D in France showing a significant reduction in HbA1c and body weight.
- | Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Semaglutide shortage puts pharmacy compounders in spotlight. https://t.co/ciUSWJZgzN @novonordisk #ozempic (Twitter) - Jun 4, 2023
- || Ozempic (semaglutide SC once-weekly) / Novo Nordisk
Clinical, Journal, Real-world evidence, Real-world: Real-World Use of Once-Weekly Semaglutide in Thai Patients With Type 2 Diabetes Mellitus in a Private Hospital Setting. (Pubmed Central) - Jun 3, 2023
No cases of pancreatitis, cancer, or progressive retinopathy were observed. In this single center undertaking, it was shown that in among persons with T2DM and obesity in Thailand, semaglutide was associated with short-term glycemic control and weight loss comparable with what has been observed in randomized clinical trials and other RWE.